Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Lymphoid 1

Conditions

Oligodendroglioma 1Lymphoma, Follicular 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 12pembrolizumab 9Biopsy 8Nivolumab 7Radiotherapy 6Specimen Handling 5Radiosurgery 4Cyclophosphamide 4fludarabine 3X-Rays 3Temozolomide 3Rituximab 3Paclitaxel 3Leukapheresis 3Dexamethasone 3Aspirin 3perflutren 2alovudine 2Vaccines 2Tirzepatide 2Surgical Procedures, Operative 2Positron-Emission Tomography 2Phantoms, Imaging 2Niacinamide 2Neoadjuvant Therapy 2Losartan 2Letrozole 2Ketoconazole 2Irinotecan 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Ketoconazole × 90 days × Clear all
NCT07585851 2026-05-14

Administration of Repurposed Ketoconazole in Glioma Patients

Universitas Padjadjaran

Phase EARLY_PHASE1 Active not recruiting
80 enrolled
CNSLymphoid

Glioblastoma, Lymphoma, Follicular

NCT03796273 2026-03-20

Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
15 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡